GTF2IRD1 in Craniofacial Development of Humans and Mice
2005; American Association for the Advancement of Science; Volume: 310; Issue: 5751 Linguagem: Inglês
10.1126/science.1116142
ISSN1095-9203
AutoresMay Tassabehji, Peter Hammond, Annette Karmiloff‐Smith, Pamela Thompson, Snorri S. Thorgeirsson, Marian E. Durkin, Nicholas C. Popescu, Timothy Hutton, Kay Metcalfe, Agnes K Rucka, Helen Stewart, Andrew Read, Mark Maconochie, Dian Donnai,
Tópico(s)Nuclear Receptors and Signaling
ResumoCraniofacial abnormalities account for about one-third of all human congenital defects, but our understanding of the genetic mechanisms governing craniofacial development is incomplete. We show that GTF2IRD1 is a genetic determinant of mammalian craniofacial and cognitive development, and we implicate another member of the TFII-I transcription factor family, GTF2I , in both aspects. Gtf2ird1 -null mice exhibit phenotypic abnormalities reminiscent of the human microdeletion disorder Williams-Beuren syndrome (WBS); craniofacial imaging reveals abnormalities in both skull and jaws that may arise through misregulation of goosecoid , a downstream target of Gtf2ird1 . In humans, a rare WBS individual with an atypical deletion, including GTF2IRD1 , shows facial dysmorphism and cognitive deficits that differ from those of classic WBS cases. We propose a mechanism of cumulative dosage effects of duplicated and diverged genes applicable to other human chromosomal disorders.
Referência(s)